» Articles » PMID: 24746901

Behavioral Effects of Perinatal Opioid Exposure

Overview
Journal Life Sci
Publisher Elsevier
Date 2014 Apr 22
PMID 24746901
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Opioids are among the world's oldest known drugs used mostly for pain relief, but recreational use is also widespread. A particularly important problem is opioid exposure in females, as their offspring can also be affected. Adverse intrauterine and postnatal environments can affect offspring development and may lead to various disabilities later in life. It is clear that repetitive painful experiences, such as randomly occurring invasive procedures during neonatal intensive care, can permanently alter neuronal and synaptic organization and therefore later behavior. At the same time, analgesic drugs can also be harmful, inducing neuronal apoptosis or withdrawal symptoms in the neonate and behavioral alterations in adulthood. Hence, risk-benefit ratios should be taken into consideration when pain relief is required during pregnancy or in neonates. Recreational use of opioids can also alter many aspects of life. Intrauterine opioid exposure has many toxic effects, inducing poor pregnancy outcomes due to underdevelopment, but it is believed that later negative consequences are more related to environmental factors such as a chaotic lifestyle and inadequate prenatal care. One of the crucial components is maternal care, which changes profoundly in addicted mothers. In substance-dependent mothers, pre- and postnatal care has special importance, and controlled treatment with a synthetic opioid (e.g., methadone) could be beneficial. We aimed to summarize and compare human and rodent data, as it is important to close the gap between scientific knowledge and societal policies. Special emphasis is given to gender differences in the sensitivity of offspring to perinatal opioid exposure.

Citing Articles

Probiotic supplementation mitigates sex-dependent nociceptive changes and gut dysbiosis induced by prenatal opioid exposure.

Singh S, Abu Y, Antoine D, Gomez D, Tao J, Truitt B Gut Microbes. 2025; 17(1):2464942.

PMID: 39950489 PMC: 11834462. DOI: 10.1080/19490976.2025.2464942.


Disrupted neuregulin 1-ErbB4 signaling: Consequences of prenatal morphine exposure in rat pups and molecular gateway to neurological impairment.

Khayat S, Fanaei H, Hafezinouri H, Ghanbarzehi A, Parsi-Moud A, Mirzaei I Toxicol Rep. 2024; 13:101687.

PMID: 39109071 PMC: 11301239. DOI: 10.1016/j.toxrep.2024.101687.


Molecular and long-term behavioral consequences of neonatal opioid exposure and withdrawal in mice.

Dunn A, Robinson S, Nwokafor C, Estill M, Ferrante J, Shen L Front Behav Neurosci. 2023; 17:1202099.

PMID: 37424750 PMC: 10324024. DOI: 10.3389/fnbeh.2023.1202099.


Body size and brain volumetry in the rat following prolonged morphine administration in infancy and adulthood.

Taylor M, Cheng A, Hodkinson D, Afacan O, Zurakowski D, Bajic D Front Pain Res (Lausanne). 2023; 4:962783.

PMID: 36923651 PMC: 10008895. DOI: 10.3389/fpain.2023.962783.


Effects of prenatal opioid exposure on synaptic adaptations and behaviors across development.

Simmons S, Grecco G, Atwood B, Nugent F Neuropharmacology. 2022; 222:109312.

PMID: 36334764 PMC: 10314127. DOI: 10.1016/j.neuropharm.2022.109312.